4.6 Article

Necdin and Neurotrophin Receptors: Interactors of Relevance for Neuronal Resistance to Oxidant Stress

期刊

PEDIATRIC RESEARCH
卷 69, 期 4, 页码 279-284

出版社

NATURE PUBLISHING GROUP
DOI: 10.1203/PDR.0b013e31820a5773

关键词

-

资金

  1. National Institute of Health [NS038569]
  2. Golisano Children's Hospital of the University of Rochester Medical Center

向作者/读者索取更多资源

Necdin is a protein known to interact with the neurotrophin receptors, neurotrophic tyrosine kinase receptor type 1 (TrkA) and 75 kD low-affinity neurotrophin receptor (p75NTR). TrkA and p75NTR play roles in development and disease of the nervous system and chemoresistance of nervous system tumors. Necdin deletion is associated with Prader-Willi syndrome. The present studies demonstrate that the effects of necdin on the susceptibility of neuroblastoma cells to oxidant stress are dependent on the ratio of p75NTR to TrkA in the cell. In low p75NTR:TrkA ratio cells, necdin down-regulation decreases sensitivity to oxidant stress and expression of and signaling through TrkA. In high p75NTR:TrkA cells, necdin down-regulation is without effect. The effects of necdin deletion on the developing nervous system may depend on the relative expression of p75NTR and TrkA in the cells of particular regions of the nervous system. (Pediatr Res 69: 279-284, 2011)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma

Allison Eberhardt, Jeanne N. Hansen, Jan Koster, Louis T. Lotta, Simeng Wang, Emmett Livingstone, Kun Qian, Linda J. Valentijn, Yujun George Zheng, Nina F. Schor, Xingguo Li

ONCOTARGET (2016)

Article Biochemistry & Molecular Biology

Methylation of the phosphatase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies

Xingguo Li, Allison Eberhardt, Jeanne N. Hansen, Dirk Bohmann, Haitao Li, Nina F. Schor

FASEB JOURNAL (2017)

Editorial Material Clinical Neurology

Autism today Have we put the cart before the horse?

Shafali S. Jeste, Nina F. Schor

NEUROLOGY (2017)

Article Education, Scientific Disciplines

The Decanal Divide: Women in Decanal Roles at US Medical Schools

Nina F. Schor

ACADEMIC MEDICINE (2018)

Editorial Material Clinical Neurology

A Life at the Interface: The 2017 Hower Award Lecture

Nina F. Schor

PEDIATRIC NEUROLOGY (2018)

Editorial Material Clinical Neurology

Women in medical school leadership positions: Implications for research

Nina F. Schor

ANNALS OF NEUROLOGY (2019)

Editorial Material Biochemistry & Molecular Biology

Career equity in medicine

Nina F. Schor

NATURE MEDICINE (2021)

Review Biotechnology & Applied Microbiology

Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary

Jill A. Morris, Chris H. Boshoff, Nina F. Schor, Ling M. Wong, Guangping Gao, Beverly L. Davidson

Summary: NINDS organized a workshop on gene-targeted therapies for CNS disorders, bringing together experts from various fields to identify challenges and propose solutions. Prior to the workshop, key obstacles and research gaps were identified through pre-meeting teleconferences, allowing for problem-solving discussions and strategy development at the workshop.

MOLECULAR THERAPY (2021)

Letter Biotechnology & Applied Microbiology

NINDS launches network to develop treatments for ultra-rare neurological diseases

Nina F. Schor, Amir P. Tamiz, Walter J. Koroshetz, Ann-Marie Broome, Julia L. Bachman, Chris Boshoff, Janice Cordell, Neel T. Dhruv, Amelie Gubitz, Adam L. Hartman, Walter J. Koroshetz, Genevieve E. Lind, Codrin I. Lungu, Jill A. Morris, Glen H. Nuckolls, Shantadurga Rajaram, Ranga Rangarajan, Rebecca A. Roof, Nina F. Schor, Mario H. Skiadopoulos, Natalia Strunnikova, Amir P. Tamiz, Ling M. Wong, Clinton B. Wright

NATURE BIOTECHNOLOGY (2021)

Review Clinical Neurology

Neurodevelopmental Clues to Neurodegeneration

Nina F. Schor, Diana W. Bianchi

Summary: Neurodegenerative disorders are typically associated with neuronal loss in late life, but recent studies have found protein abnormalities related to these disorders in childhood, suggesting a potential for identifying susceptibility and prevention clues before disease symptoms manifest.

PEDIATRIC NEUROLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

The NINDS 2021-2026 Strategic Plan: Partnership and cross-cutting principles

Nina F. Schor, Paul Scott, Elizabeth Y. Litvina, Christine Torborg, Jenny Kim, Robert Zalutsky, Amy Bany Adams

Summary: The 2021-2026 Strategic Plan of the National Institute of Neurological Disorders and Stroke is a detailed explanation of the institute's vision, mission, and strategic objectives. It emphasizes cross-cutting operational principles including scientific rigor, communication, workforce culture, and equity.
Article Clinical Neurology

Planning and Implementing Strategically Year 1 of the NINDS 2021-2026 Strategic Plan

Nina F. Schor, Paul Scott, Elizabeth Y. Litvina, Christine Torborg, Jenny L. Kim, Robert Zalutsky, Amy Bany Adams

Summary: This article presents the accomplishments, new initiatives, and opportunities of an institute of the National Institutes of Health (NIH) in implementing its strategic plan over the past year. It also provides a preview of the metrics and benchmarks that will be used to measure the future progress of the strategic plan.

NEUROLOGY (2022)

Article Clinical Neurology

Academic Neurology and the COVID-19 Pandemic Resilience, Hope, and Solutions

Nina F. Schor, Merit E. Cudkowicz, Brenda Banwell

Summary: The COVID-19 pandemic has had a significant impact on the field of academic neurology, affecting research activities, clinical trials, and patient care. The pandemic has posed threats to neuroscience research and led to delays in clinical trial enrollment, but it has also prompted innovative remote engagement strategies. Clinical care has faced challenges, but telehealth has emerged as a valuable tool for neurologists to continue providing care and connecting with patients.

NEUROLOGY (2023)

Review Biochemistry & Molecular Biology

Using Chemistry to Target Neuroblastoma

Jeanne N. Hansen, Xingguo Li, Y. George Zheng, Louis T. Lotta, Abhishek Dedhe, Nina F. Schor

ACS CHEMICAL NEUROSCIENCE (2017)

暂无数据